This document provides information on various protozoan parasites that infect the gastrointestinal tract, known as enteric coccidia. It defines protozoa and describes their characteristic features including morphology, locomotion, reproduction, and classification. It then focuses on the phylum Apicomplexa, outlining the main characteristics and providing examples such as Eimeria, Isospora, Cryptosporidium, and Cyclospora. The document discusses the life cycles, pathogenesis, diagnosis and control of these important enteric coccidia, emphasizing their clinical significance and the different disease syndromes they can cause in hosts.
Theileriosis Presented by Ahmed Abdulkadir Hassan
4th year student, college of veterinary medicine,
University of Bahri.
kadle010@gmail.com
khartoum, Sudan.
After showing this Presentation you will able to differentiate between each type of intestinal parasite in cattle.
In this Presentation we will study the life cycle of each type
And we will able to make control ,prevention and treatment of each type
Theileriosis Presented by Ahmed Abdulkadir Hassan
4th year student, college of veterinary medicine,
University of Bahri.
kadle010@gmail.com
khartoum, Sudan.
After showing this Presentation you will able to differentiate between each type of intestinal parasite in cattle.
In this Presentation we will study the life cycle of each type
And we will able to make control ,prevention and treatment of each type
Classification of medical parasitology Lec.2.pptxnedalalazzwy
Parasitology is the scientific discipline concerned with the study of the biology of parasites and parasitic diseases, including the distribution, biochemistry, physiology, molecular biology, ecology, evolution and clinical aspects of parasites, including the host response to these agents.
Strategies Novartis can use to GROW from a Billion Dollar Company to a Trillion Dollar Company like Alphabet Inc
Novartis is a leading healthcare company which is situated in Switzerland and uses digital technologies and innovative science to come up with transformative ways of treatment in areas of great medicinal needs. This article explains what Novartis strategies and what they should employ so that they can rise from a billion dollar company to a trillion dollar company like the Google Alphabet Inc.
Novartis was formed in March 1996 by the merging of pharmaceutical and agrochemical divisions of Ciba-Geigy and Sandoz companies. Thanks to the merging of the two companies, Novartis is one of the biggest pharmaceutical companies in the world. Novartis is one of the largest companies which achieved a great milestone within a few decades. Novartis as a whole is divided into three major divisions: Sandoz (generics), Innovative Medicines and Alcon (eyecare). Novartis is also involved in collaborative research projects that are publicly funded.
Below are some of Novartis best selling drugs and their revenue
1.Cosenty – This is the top selling drug with a revenue of 4.788 billion dollars
2.Enfresto – This has a revenue of 4.644 billions dollars
3.Promacta – This has a revenue 0f 2.088 billion dollars
Medicine manufactured by Novartis and their uses
Medicine Medicine use
Cosentyx Used to treat psoriatic arthritis
Entresto Used to treat heart failure
Lucentis Used to block abnormal vessel growth in the back of the eye
Tasigna Used to treat chronic myelogenous leukemia which has the Philadelphia chromosome
Jakavi Used to treat myelofibrosis, polycythemia vera and graft-versus-host disease
Promacta Used to treat patients with abnormal low platelet count
Sandostatin Used to treat patients with tumor experiencing symptoms like flushing and diarrhea
Xolair Used to treat moderate and severe asthma
Gilenya Used to treat multiple sclerosis
How Novartis became one of the biggest pharmaceutical companies in the world
1.Market control through partnership
Geigy, Sandoz and Ciba combined their power so that they can compete with strong foreign firms and formed a cartel called the Basal Syndicate or Basal IG. Basal IG secured most of the manufacturing facilities all over the US and across Europe. It later joined with IG Farben and other chemical companies to form a big cartel called the Quadrapartite Cartel which dominated all of the European market and enjoyed the profits made from the joint manufacturing.
2.Growth acceleration through mergers
Since competition was very rampant in the pharmaceutical industry, Ciba and Geigy decided to merge with Sandoz AG to form Novartis. With this merge, Novartis became one of the growing giants in the pharmaceutical industry. This made Novartis gain a lot of fame and build a strong reputation over other companies. Novartis majored on agrochemical and pharmaceutical industries which made it easy to focus on a specific mar
LUMEN DWELLING FLAGELLATES - GIARDIA
REFS:
INTERNATIONALLY ACCEPTED BOOK OF MEDICAL PARASITOLOGY BY K. D. CHATTERJEE
TEXT BOOK OF MEDICAL PARASITOLOGY BY PANIKER
IMAGE SOURCES : FROM INTERNET
Zoonotic parasite; Toxoplasma is an opportunistic pathogen.
Infects animals, cattle, birds, rodents, pigs, and sheep.
and humans.
Causes the disease Toxoplasmosis
Strategies Novartis can use to GROW from a Billion Dollar Company to a Trillion Dollar Company like Alphabet Inc
Novartis is a leading healthcare company which is situated in Switzerland and uses digital technologies and innovative science to come up with transformative ways of treatment in areas of great medicinal needs. This article explains what Novartis strategies and what they should employ so that they can rise from a billion dollar company to a trillion dollar company like the Google Alphabet Inc.
Novartis was formed in March 1996 by the merging of pharmaceutical and agrochemical divisions of Ciba-Geigy and Sandoz companies. Thanks to the merging of the two companies, Novartis is one of the biggest pharmaceutical companies in the world. Novartis is one of the largest companies which achieved a great milestone within a few decades. Novartis as a whole is divided into three major divisions: Sandoz (generics), Innovative Medicines and Alcon (eyecare). Novartis is also involved in collaborative research projects that are publicly funded.
Below are some of Novartis best selling drugs and their revenue
1.Cosenty – This is the top selling drug with a revenue of 4.788 billion dollars
2.Enfresto – This has a revenue of 4.644 billions dollars
3.Promacta – This has a revenue 0f 2.088 billion dollars
Medicine manufactured by Novartis and their uses
Medicine Medicine use
Cosentyx Used to treat psoriatic arthritis
Entresto Used to treat heart failure
Lucentis Used to block abnormal vessel growth in the back of the eye
Tasigna Used to treat chronic myelogenous leukemia which has the Philadelphia chromosome
Jakavi Used to treat myelofibrosis, polycythemia vera and graft-versus-host disease
Promacta Used to treat patients with abnormal low platelet count
Sandostatin Used to treat patients with tumor experiencing symptoms like flushing and diarrhea
Xolair Used to treat moderate and severe asthma
Gilenya Used to treat multiple sclerosis
How Novartis became one of the biggest pharmaceutical companies in the world
1.Market control through partnership
Geigy, Sandoz and Ciba combined their power so that they can compete with strong foreign firms and formed a cartel called the Basal Syndicate or Basal IG. Basal IG secured most of the manufacturing facilities all over the US and across Europe. It later joined with IG Farben and other chemical companies to form a big cartel called the Quadrapartite Cartel which dominated all of the European market and enjoyed the profits made from the joint manufacturing.
2.Growth acceleration through mergers
Since competition was very rampant in the pharmaceutical industry, Ciba and Geigy decided to merge with Sandoz AG to form Novartis. With this merge, Novartis became one of the growing giants in the pharmaceutical industry. This made Novartis gain a lot of fame and build a strong reputation over other companies. Novartis majored on agrochemical and pharmaceutical industries which made it easy to focus on a specific mar
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
2. What are Protozoa?
The characteristic features of Protozoa,
Morphology
Locomotion
Reproduction: Asexual reproduction, Sexual reproduction
Classification
The main characters of Phylum Apicomplexa.
Enteric coccidia:Cystisospora, and Cyclospora.
3. Classification of Protozoa
Kingdom Protozoa
Group 1 Apicomplexa (Sporozoa) e.g. Eimeria
Group 2 Mastigophora (Flagellates) e.g.
Trypanosoma
Group 3 Ciliophora (Ciliates) e.g. Balantidium
Group 4 Amoeba( sarcodina)
e.g.Entamoeba
Group 5 Microspora moved to the kingdom Fungi, as
the phylum Microsporidia- e.g. Encephalitozoon
8. Intracytoplasmic
Mainly enteric except:
-E.stiedae (liver of rabbit),
-E.truncata (kidney of goose)
Affect all animals except dog and cat
Causes a sever disease called: Coccidiosis
9. Cosmopolitan
Spreading of the disease increases in winter and
spring(humidity)
Intensive breeding farms are highly susceptible
10. Monoxenous parasite
Host specific
Cell specific
Multiplication of the parasitic stages occurs in:-epithelial
cells of mucosa or may reach sub mucosa of the intestine
Except: E.stiedae & E.truncata.
Multiplication is mostly intracytoplasmic except some
species (E.alabamensis) which multiplies inside the
nucleus.
22. Requirments of sporulation:
*Oxygen
*Adequate moisture
*Temprature
Time required for sporulation:1-7
days(except:Eimeria of camel,17 days).
Sporulated oocysts are more resistant to
environmental conditions than unsporulated
oocysts.
31. Epidemiology
■ Coccidial infections are self-limiting
i.e. (in the absence of re-infection, one cycle of
development can take place).
■ Under natural infections, repeated infection usually
occurs in closed farms.
■ Repeated infections with small number of oocysts,
induce the development of immunity.
■ Old ages are immune hosts (carriers).
32.
33.
34. Depends on:
1. Location of the parasite in the host tissue.
2. Size of the infecting dose.
3. Acquired immunity.
4. Age of the host.
5. Species of the parasite.(Virulence)
parasite can destroy epithelial cells causing villus atrophy &
hemorrhage is seen in severe disease
majority of pathology caused by asexually replicating stages vs.
sexual stages, therefore see clinical signs of disease prior to
presence of oocysts
35. Diarrhea
blood may or may not be observed in feces
(depends on species & severity of infection)
poor weight gain, emaciation & death
Death or acquired immunity and self cure
36. The most pathogenic and important species in domestic
poultry
Chicken huddle together& stop feeding.
Hemorrhagic enteritis.
Mortality is highest between 4th
&6th
day due to
excessive loss of blood.
E.tenellaE.tenella
62. Many different drugs have been used for therapy:
(coccidiostatics e.g. Amprolium, Sulfa drugs, Some drugs have
a cidal effect (e.g. Panzuril, Diclazuril, Toltrazuril) mixed with
food or water.
Used for 3-5 days for treatment
&repeated after 10-14 days + Good hygiene.
63. - Prophylactic programs: Rotation of anticoccidial drugs to prevent
the drug resistance:
A-Shuttle program.
B-Switch program (slow rotation)
- Environment - reducing exposure to oocysts through good management can
prevent or reduce severity of disease. e.g Good sanitation.
- oocysts resistant to most disinfectants but steam cleaning, immersion in
boiling water or 10% ammonia solutions (e.g. food & water bowls) .
- Vaccination.
64. Species E.tenella E.necatrix E.acervulina
Pathoginicity Pathogenic Less
pathogenic
Lcalization Caecum Mid
S.I(Schizont)
&caecum(Ga
mont)s
Anterior S.I
72. -Extracytoplasmic coccidian protozoans.
-- Intracellular, extra-cytoplasmic parasites of
epithelial cells lining the gastrointestinal and
respiratory tracts of many different vertebrates
■ Attached to the luminal border of host cells,
enveloped in parasitophorus membrane.
■ Zoonotic parasite
G. CryptosporidiumG. Cryptosporidium
74. Sporozoites, Merozoites, Meronts and Gamonts
- similar to Eimeria
Oocysts
oocysts are spherical and very small 4 - 6 um
all are sporulated (therefore immediately infective) when
passed in feces
- Cryptosporidium oocysts contain 4 ‘naked’ sporozoites (no
sporocysts).
77. Pathogenesis and symptoms of
cryptosporidiosis
■More pathogenic in young hosts 1-3 months.
■Catarrhal enteritis – watery diarrhea
■Pneumonia, swelling of bursa in birds.
■Also, sings of other complications
AIDS and Esch.coli.
78.
79.
80.
81.
82. Diagnosis
■Symptoms
General intestinal or respiratory troubles.
■Lab. exam
□ Direct fecal examination using Sugar concentration
technique, examined under oil immersion x100.
□Stained fecal smears use Modified Zeihl– Nelseen
(MZN stain(.
□ Histopathological exam.
Immunofluorescence antibody.
83.
84. - Good diagnosis
- no treatment currently available, although halofuginone &
azithromycin have recently (2008) shown some efficacy in calves
- sanitation and good management practices are necessary to
reduce exposure to oocysts
- supportive care (fluids, electrolytes, reduce stress)
- adequate nutrition
- cryptosporidosis may be a chronic disease of the
immunocompromised and can be life threatening (AIDS patients,
immunosuppressive therapy)
- calves & lambs must receive adequate colostrum.
ControlControl